Condensed Consolidated Balance Sheets (unaudited) - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
Current Assets:
Cash and cash equivalents	$ 292.1	$ 375.7
Accounts receivable, less allowance for credit losses	1,340.7	1,381.5
Inventories	2,323.3	2,147.2
Prepaid expenses and other current assets	415.8	522.9
Total Current Assets	4,372.0	4,427.3
Property, plant and equipment, net	2,032.2	1,872.5
Goodwill	8,710.4	8,580.2
Intangible assets, net	4,891.7	5,063.8
Other assets	1,211.0	1,122.2
Total Assets	21,217.3	21,066.0
Current Liabilities:
Accounts payable	319.7	354.1
Income taxes payable	97.1	38.5
Other current liabilities	1,299.8	1,421.3
Current portion of long-term debt	355.0	544.3
Total Current Liabilities	2,071.5	2,358.2
Deferred income taxes, net	465.4	474.8
Long-term income tax payable	403.1	421.2
Other long-term liabilities	631.9	632.6
Long-term debt	5,127.4	5,152.2
Total Liabilities	8,699.3	9,039.0
Commitments and Contingencies (Note 16)
Stockholders' Equity:
Common stock, $0.01 par value, one billion shares authorized, 316.0 million shares as of September 30, 2023 (313.8 million as of December 31, 2022) issued	3.2	3.1
Paid-in capital	9,801.4	9,504.4
Retained earnings	10,014.9	9,559.3
Accumulated other comprehensive loss	(186.5)	(179.3)
Treasury stock, 107.0 million shares as of September 30, 2023 (104.8 million as of December 31, 2022)	(7,122.2)	(6,867.2)
Total Zimmer Biomet Holdings, Inc. stockholders' equity	12,510.8	12,020.3
Noncontrolling interest	7.2	6.7
Total Stockholders' Equity	12,518.0	12,027.0
Total Liabilities and Stockholders' Equity	$ 21,217.3	$ 21,066.0